echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Blood System > Blood: Bcl-2 member expresses changes that reveal CLL Venetok drug resistance mechanism

    Blood: Bcl-2 member expresses changes that reveal CLL Venetok drug resistance mechanism

    • Last Update: 2020-07-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Chronic lymphocytic leukemia (CLL) cells circulate between lymph nodes (LN) and peripheral blood (PB), and members of the Bcl-2 family show significant swaying between these chambersSpecifically, Bcl-XL and Mcl-1, not targets for Bcl-2 inhibitor Vinatok, are expressed in LN for an increaseGiven that Ilutinib promotes the separation of CLL cells from LN, the researchers speculate that Ilutini may have affected the expression of Bcl-XL and Mcl-1 after the CLL cells were removed from LN, making TheC Cells sensitive to VinatokAs a result, the researchers studied the expression of members of the Bcl-2 family in patients treated with Ilutini or Vinatok, and parsed the functional interactions of Bcl-2 family members in in an in vitro model of Vinatok drug resistancein the PB, the expression levels of Bcl-XL and Mcl-1 in cells that have just migrated from LN are higher than those of the cells that migrate LNWhen Ilutinib was treated, the difference disappeared, and in particular, in patients who relapsed after Ilutinib treatment, the difference recursbut the early increase in bcl-2 family members during the veneertok treatment suggests that the two drugs act differentlyIn CLL cells that are completely resistant to Vinatok (caused by Bcl-XL, McL-1 and Bfl-1 induction led by CD40), the BH3 analog was used for spectral analysisThe double or triple combinations of several BH3 simulations have a high degree of synergy in restoring the lethal effect of CLL cellsfinally, the researchers confirmed that the apoptotic protein Bim interacts in a certain order with members of the anti-apoptosis Bcl-2: Bcl-XL-Mcl-1 Bfl-1, this study shows that Bcl-XL plays a more important role in Vinatok resistance than Mcl-1, providing a biological basis for potential synergies between Irutini and Vinatok
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.